Cancer care 'time-bomb' warning over doctor shortages in Scotland
Dr Katharine Halliday, president of the RCR, said: "Patients are being failed by a chronic lack of radiologists and oncologists."Despite the best efforts of NHS staff, there aren't enough doctors to ensure prompt, safe and effective care and the outlook is bleak."The government must train up more radiologists and oncologists to defuse this ticking time bomb for cancer diagnosis and treatment."The two RCR reports show the results of a "workforce census" of clinical radiology and clinical oncology staff in 2024.They show regional disparities in staff shortages, with 34 radiologists currently needed to meet demand in the north of Scotland, whereas nine are needed in south-east Scotland.The north of Scotland is also expected to see a 43% shortfall in the number of oncologists by 2029, compared with 31% across Scotland as a whole.
Neil Gray told the BBC's Good Morning Scotland programme: "We've got a 40% increase in the number of radiologists from 10 years ago, and a 27% increase in the number of oncologists compared to 10 years ago, and we're supporting the training of more so that we can help to address the demand that there is in the system."He added there has been a increased demand on cancer services, and the NHS is treating more patients than it was 10 years ago.Gray added: "We need to both address the demand upon services, which is what we are seeking to do by reducing waiting times, but also seek to reduce the potential for people to have to seek cancer services by addressing the population health reasons as to why there is an increased level of cancer in society."The reports also detail a "retention crisis" among cancer specialists - the median age of consultant clinical radiologists leaving the NHS was 38 in 2024, compared with 58 the year before.Seven in 10 leavers last year were also under the age of 45.Gray added that government is also investing in wellbeing measures to help improve staff retention.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
3 hours ago
- The Independent
Why cancer patients may have to avoid popular sugar substitute
New research from the University of Pittsburgh and UPMC Hillman Cancer Center suggests that sucralose, a popular sugar substitute, may interfere with the effectiveness of certain cancer treatments. Patients with melanoma and non-small cell lung cancer who consumed high levels of sucralose responded worse to immunotherapy and had poorer survival rates. The study, primarily conducted on mice, found that sucralose disrupts gut bacteria, leading to a depletion of the amino acid arginine, which is essential for T-cell function and effective immunotherapy. Researchers discovered that supplementing with arginine counteracted the negative effects of sucralose on immunotherapy treatments in mice. Future plans include pursuing clinical trials to determine if arginine supplementation can mitigate sucralose's effects in humans and investigating the impact of other artificial sweeteners on the immune system and cancer treatments.
Daily Mail
3 hours ago
- Daily Mail
The dangerous ingredients tied to cancer and dementia lurking in America's favorite canned cocktails
With summer in full swing, experts are warning against enjoying popular canned cocktails over fears they may accelerate cancer development. Alcohol is classified as a Group 1 carcinogen, meaning that it can cause damage to cell DNA. Your browser does not support iframes.
The Guardian
3 hours ago
- The Guardian
Deal or no deal? World leaders walk tightrope in tariff negotiations with Trump
It was grip-and-grin time for Ursula von der Leyen as she sat across from Donald Trump in Scotland last week, with the two announcing a deal for 15% tariffs on European imports that would avert a transatlantic trade war – but came at a stiff price for the 27-country bloc. After committing to a unilateral US raise on tariffs that came on the heels of a Nato commitment to increase defense spending to 5% of national GDPs, von der Leyen then thanked Trump 'for his personal commitment and his leadership to achieve this breakthrough'. 'He is a tough negotiator, but he is also a dealmaker,' she said, as the US president beamed. The EU was one of just a number of parties to strike a deal with Trump before his temporary pause on new tariffs came to an end this week. And like many others, the guiding principle for the EU appeared to be: it can always get worse. 'This is clearly the best deal we could get under very difficult circumstances,' Maroš Šefčovič, the EU trade chief, said. Others had a far bleaker interpretation of the dynamics, as Trump has wielded the threat of sky-high tariffs to cudgel his trading partners into submission. 'It is a dark day when an alliance of free peoples, brought together to affirm their common values and to defend their common interests, resigns itself to submission,' wrote the French prime minister, François Bayrou. Hungarian prime minister Viktor Orbán put it another way: 'It was Donald Trump eating Ursula von der Leyen for breakfast,' he said on his podcast. Later, he called her a 'featherweight'. World leaders have been forced to adopt a position of appeasement and pragmatism as they've approached the Trump administration, which has swung between imposing staggering tariffs on imports and then announcing last minute pauses and exclusions that suggest there is little rhyme or reason to the White House's tariff strategy. But the key factor for Trump appears to be taking whatever he can get. Countries across Asia exporting to the US were quickest to begin negotiating new trade deals with the White House. Vietnam was desperate to cut a 46% tariff imposed on the country, and Trump early last month announced that he had negotiated a 20% rate with Vietnamese negotiators. Except, it turned out, they believed that they had negotiated an 11% rate, Politico reported. And treasury secretary Scott Bessent this week admitted that he had never seen the deal, which the Vietnamese authorities have never confirmed. Trump reportedly used the trade threats along with other incentives in order to broker a recent peace between Thailand and Cambodia after fighting broke out along the border between the two countries. He soon announced a 19% rate – a significant cut from 49% for Cambodia and 36% for Thailand – which appeared more motivated by international politics than trade considerations. But while many countries in the region will breathe a sigh of relief as they avert sky-high tariffs, some see a new danger in the arbitrary redrawing of the US's trade relationship with the world. 'What we felt during this negotiation is that the US trade environment is fundamentally changing,' South Korean trade minister Yeo Han-koo said shortly after a deal was made to tariff imports at 15%, down from a threatened 25%. The two sides had made a verbally agreement but had not made a formal draft, he said, because the deal had to be struck so quickly. 'I think we are entering a new normal era,' he said. 'So, although we have overcome this crisis, we cannot be relieved, because we do not know when we will face pressure from tariffs or non-tariff measures again.' Leaders who have stood up to Trump are having the hardest time. Among others, Trump has focused his ire on Canada, which he has blamed for the fentanyl crisis in the US, a charge that Canada's prime minister Mark Carney has rejected. Trump on Friday announced that he would raise tariffs on Canada, a top trading partner, to 35%, as tough negotiations between the two sides continued. Carney, who had coined the elections slogan 'Elbows up, Canada' as a signal of defiance against Trump's tariff and annexation threats, said he was 'disappointed'. 'While we will continue to negotiate with the United States on our trading relationship, the Canadian government is laser focused on what we can control: building Canada strong,' Carney said.
